retatrutide fat loss clinical trial results Weight Results:Trial Data and FDA Status Retatrutide Weight Loss Treatment Explained

Working with a knowledgeable provider ensures you have access to the most up-to-date, evidence-based options tailored to your needs

Retatrutide is an investigational drug and not for diagnostic or therapeutic use in humans

On the other hand, if you tolerate the once-weekly injection well and are seeing consistent results, there is little reason to switch

A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control

The injectable format allows Retatrutide to bypass digestive absorption issues that limit oral medications

Patients who are pregnant, nursing, or have certain conditions (such as pancreatitis, gallbladder disease, or thyroid cancer) may not be eligible